Search research articles
Contact Us
Filters
Showing results (121-130 of 134) with videos related to
Page
of 14
Sort By:
The Lancet Regional Health. Europe
|
April 24, 2023
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study
Kausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
American Journal of Preventive Cardiology
|
June 15, 2026
Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: a simulation from the SANTORINI study
Kausik K Ray, Carlos Aguiar, Marcello Arca, et al.
European Journal of Preventive Cardiology
|
June 11, 2024
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study
Kausik K Ray, Carlos Aguiar, Marcello Arca, et al.
Atherosclerosis
|
July 24, 2018
Prognostic value of pulse pressure after an acute coronary syndrome
Brahim Harbaoui, David Nanchen, Pierre Lantelme, et al.
Bioscience Reports
|
March 19, 2025
Development and validation of an epigenetic signature of allostatic load
Jonviea D Chamberlain, Daniel Ackermann, Murielle Bochud, et al.
JAMA Network Open
|
April 13, 2026
Genetic Cascade Screening for Familial Hypercholesterolemia: A Randomized Clinical Trial
David Nanchen, Aziz Chaouch, Renzo Scuderi, et al.
Atherosclerosis
|
June 7, 2023
Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis
Simon Kraler, Florian A Wenzl, Jody Vykoukal, et al.
European Heart Journal
|
May 4, 2019
Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes
Xinmin S Li, Slayman Obeid, Zeneng Wang, et al.
Heart (British Cardiac Society)
|
March 22, 2015
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland
Roland Klingenberg, Dik Heg, Lorenz Räber, et al.
European Heart Journal
|
January 13, 2017
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors
Xinmin S Li, Slayman Obeid, Roland Klingenberg, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 134) with videos related to
Sort By:
Page
of 14
The Lancet Regional Health. Europe
|
April 24, 2023
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study
Kausik K Ray, Inaam Haq, Aikaterini Bilitou, et al.
American Journal of Preventive Cardiology
|
June 15, 2026
Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: a simulation from the SANTORINI study
Kausik K Ray, Carlos Aguiar, Marcello Arca, et al.
European Journal of Preventive Cardiology
|
June 11, 2024
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study
Kausik K Ray, Carlos Aguiar, Marcello Arca, et al.
Atherosclerosis
|
July 24, 2018
Prognostic value of pulse pressure after an acute coronary syndrome
Brahim Harbaoui, David Nanchen, Pierre Lantelme, et al.
Bioscience Reports
|
March 19, 2025
Development and validation of an epigenetic signature of allostatic load
Jonviea D Chamberlain, Daniel Ackermann, Murielle Bochud, et al.
JAMA Network Open
|
April 13, 2026
Genetic Cascade Screening for Familial Hypercholesterolemia: A Randomized Clinical Trial
David Nanchen, Aziz Chaouch, Renzo Scuderi, et al.
Atherosclerosis
|
June 7, 2023
Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis
Simon Kraler, Florian A Wenzl, Jody Vykoukal, et al.
European Heart Journal
|
May 4, 2019
Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes
Xinmin S Li, Slayman Obeid, Zeneng Wang, et al.
Heart (British Cardiac Society)
|
March 22, 2015
Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland
Roland Klingenberg, Dik Heg, Lorenz Räber, et al.
European Heart Journal
|
January 13, 2017
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors
Xinmin S Li, Slayman Obeid, Roland Klingenberg, et al.
Page
of 14